4-Bromo-2-(difluoromethyl)-5-methoxypyridine, 98%, 500mg

Boc-Ser-OMe, 95%, 500g

2-Chloro-6,7-difluoroquinoxaline, 98+%, 100mg

3,4,5-Trimethoxyphenylacetic acid, 95.0%, 5g

6-Methoxypyridine-3-sulfonyl chloride, 95.0%, 5g

1-(4-Bromophenyl)-5-methyl-1H-pyrazole-4-carboxylic acid hydrazide, 95.0%, 1g

3-Amino-1-benzothiophene-2-carboxylic acid, 97.0%, 10g

Tartrazine (CI 19140), 100 g, glass packaging

6-cyclopropyl-1-(4-methylphenyl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one, 95.0%, 250mg

N-(2-(2-(2-(2-Aminoethoxy)ethoxy)ethoxy)ethyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide, 95+%, 10g

2-Bromo-3-(3-fluoro-4-methoxyphenyl)-1-propene, 97.0%, 1g

3-(tert-Butyl)-4-methoxyphenol, 95.0%, 25g

(6-Methoxypyridin-3-yl)methylamine, 95.0%, 5g